Literature DB >> 1674719

Population frequency of the arylsulphatase A pseudo-deficiency allele.

P V Nelson1, W F Carey, C P Morris.   

Abstract

The enzymatic diagnosis of metachromatic leukodystrophy is complicated by the frequent occurrence of the pseudo-deficiency of arylsulphatase A (ASA) enzyme activity. An A to G nucleotide transition in the first polyadenylation signal of the ASA gene results in the loss of its major mRNA species and a greatly reduced level of enzyme activity. This nucleotide change (nucleotide 1620 of the ASA cDNA) is the cause of ASA pseudo-deficiency and is closely linked to another A to G transition (nucleotide 1049), within the ASA gene, which changes Asn350 to serine but which does not affect ASA activity. The distribution of these 2 nucleotide changes has been investigated in 73 unrelated individuals from the Australian population. The two transitions were found together on 14 (9.6%) out of 146 chromosomes. The transition at nucleotide 1620 was not found alone; however, the other transition was found alone on 7 (4.8%) out of the 146 chromosomes. The carrier frequency of the ASA pseudo-deficiency mutation in Australia is thus estimated to be about 20%.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1674719     DOI: 10.1007/bf01213099

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  4 in total

1.  Letter: Absence of ASA activity in healthy father of a patient with metachromatic leukodystrophy.

Authors:  G Dubois; J C Turpin; N Baumann
Journal:  N Engl J Med       Date:  1975-08-07       Impact factor: 91.245

2.  Arylsulfatase A pseudodeficiency: loss of a polyadenylylation signal and N-glycosylation site.

Authors:  V Gieselmann; A Polten; J Kreysing; K von Figura
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

3.  Pseudodeficiency of arylsulfatase A: a common genetic polymorphism with possible disease implications.

Authors:  C Hohenschutz; P Eich; W Friedl; A Waheed; E Conzelmann; P Propping
Journal:  Hum Genet       Date:  1989-04       Impact factor: 4.132

4.  Arylsulfatase A in pseudodeficiency.

Authors:  B Herz; G Bach
Journal:  Hum Genet       Date:  1984       Impact factor: 4.132

  4 in total
  9 in total

1.  Arylsulfatase A pseudodeficiency in Chinese.

Authors:  W L Hwu; L P Tsai; W C Wang; S C Chuang; P J Wang; T R Wang
Journal:  Hum Genet       Date:  1996-02       Impact factor: 4.132

Review 2.  The arylsulphatase A gene and molecular genetics of metachromatic leucodystrophy.

Authors:  M L Barth; A Fensom; A Harris
Journal:  J Med Genet       Date:  1994-09       Impact factor: 6.318

3.  Searching for mutations in the arylsulphatase A gene.

Authors:  M B Salamon; E Christensen; M Schwartz
Journal:  J Inherit Metab Dis       Date:  1994       Impact factor: 4.982

Review 4.  "Pseudodeficiencies" of lysosomal hydrolases.

Authors:  G H Thomas
Journal:  Am J Hum Genet       Date:  1994-06       Impact factor: 11.025

5.  Mucopolysaccharidosis type I (Hurler syndrome): linkage disequilibrium indicates the presence of a major allele.

Authors:  H S Scott; P V Nelson; A Cooper; J E Wraith; J J Hopwood; C P Morris
Journal:  Hum Genet       Date:  1992-03       Impact factor: 4.132

6.  Pseudodeficiency of arylsulphatase A: strategy for clarification of genotype in families of subjects with low ASA activity and neurological symptoms.

Authors:  S Leistner; E Young; C Meaney; B Winchester
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

7.  Determination of arylsulfatase A pseudodeficiency allele and haplotype frequency in the Tunisian population.

Authors:  Nizar Ben Halim; Imen Dorboz; Rym Kefi; Najla Kharrat; Eleonore Eymard-Pierre; Majdi Nagara; Lilia Romdhane; Nissaf Ben Alaya-Bouafif; Ahmed Rebai; Najoua Miladi; Odile Boespflug-Tanguy; Sonia Abdelhak
Journal:  Neurol Sci       Date:  2015-11-14       Impact factor: 3.307

8.  Frequency of arylsulphatase A pseudodeficiency associated mutations in a healthy population.

Authors:  M L Barth; C Ward; A Harris; A Saad; A Fensom
Journal:  J Med Genet       Date:  1994-09       Impact factor: 6.318

Review 9.  Developing therapeutic approaches for metachromatic leukodystrophy.

Authors:  Shilpa A Patil; Gustavo H B Maegawa
Journal:  Drug Des Devel Ther       Date:  2013-08-08       Impact factor: 4.162

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.